{"log_id": 5045204111403416485, "direction": 0, "words_result_num": 31, "words_result": [{"probability": {"variance": 0.009974, "average": 0.966457, "min": 0.477502}, "location": {"width": 564, "top": 163, "height": 25, "left": 125}, "words": "胰腺炎、史约综食征以及严重的肝功能异常(如黄疸和肝炎)。"}, {"probability": {"variance": 0.023466, "average": 0.907198, "min": 0.557471}, "location": {"width": 225, "top": 209, "height": 25, "left": 127}, "words": "利噻唑烷二酮类合用治疗"}, {"probability": {"variance": 0.004731, "average": 0.964777, "min": 0.705219}, "location": {"width": 916, "top": 256, "height": 29, "left": 166}, "words": "在一项为期24周的瑞格列东一罗格列酮或者瑞格列奈一吡格列酮合用治疗(共有250名患者参与了"}, {"probability": {"variance": 0.003867, "average": 0.971922, "min": 0.709914}, "location": {"width": 949, "top": 303, "height": 28, "left": 125}, "words": "并用药试验)的临床试验中,合用细的低血糖的(血糖<50mg/dL)发生率为7%,瑞格列奈单用为7%"}, {"probability": {"variance": 0.022435, "average": 0.857235, "min": 0.587219}, "location": {"width": 170, "top": 352, "height": 23, "left": 123}, "words": "噻唑炕二酮组为20"}, {"probability": {"variance": 0.000439, "average": 0.987402, "min": 0.920962}, "location": {"width": 920, "top": 394, "height": 32, "left": 160}, "words": "250名瑞格列奈一噻唑烷二酮合并用药的病人中有12名出现了外周型水肿,124名单用噻唑烷二酮治"}, {"probability": {"variance": 0.007774, "average": 0.9702, "min": 0.533701}, "location": {"width": 942, "top": 443, "height": 26, "left": 119}, "words": "疗的患者中有3例报道,而瑞格列奈单用组中没有报道该不良反应。当对各治疗组的脱火率进行校正后"}, {"probability": {"variance": 0.015863, "average": 0.935039, "min": 0.441109}, "location": {"width": 956, "top": 488, "height": 27, "left": 120}, "words": "瑞格列奈一噻唑烷二酮合用组的患者每24周发生外周型水肿的几率为5%,单用噻唑烷二酮组的发生儿率"}, {"probability": {"variance": 0.008181, "average": 0.958433, "min": 0.570482}, "location": {"width": 956, "top": 535, "height": 26, "left": 121}, "words": "为4%。有报道,250名瑞格列奈一噻唑烷二酮合用组患者中有2名(0.8%)出现伴随充血性心肌衰竭的外"}, {"probability": {"variance": 0.009281, "average": 0.964667, "min": 0.46317}, "location": {"width": 954, "top": 582, "height": 26, "left": 122}, "words": "周型水肿。这两名患者均有冠心病史,并在服用利尿剂后恢复。单用治疗组中并没有相关可比较的案例投"}, {"probability": {"variance": 0, "average": 0.883359, "min": 0.883359}, "location": {"width": 20, "top": 632, "height": 22, "left": 118}, "words": "道"}, {"probability": {"variance": 0.007442, "average": 0.952916, "min": 0.619655}, "location": {"width": 916, "top": 675, "height": 27, "left": 159}, "words": "瑞格列奈一噻唑烷二酮合用的平均体重变化为+4.9kg瑞格列奈一噻烷二酮组没有患者出现转氨"}, {"probability": {"variance": 0.001824, "average": 0.972699, "min": 0.877361}, "location": {"width": 308, "top": 723, "height": 24, "left": 117}, "words": "升高(定义为正常值上限的3倍)。"}, {"probability": {"variance": 2e-06, "average": 0.998627, "min": 0.996631}, "location": {"width": 76, "top": 769, "height": 26, "left": 120}, "words": "禁忌】"}, {"probability": {"variance": 0.014766, "average": 0.852311, "min": 0.701709}, "location": {"width": 125, "top": 818, "height": 22, "left": 157}, "words": "以卜销况禁用"}, {"probability": {"variance": 0.008532, "average": 0.966118, "min": 0.546911}, "location": {"width": 473, "top": 864, "height": 24, "left": 156}, "words": "1已知对瑞格列奈或本品中的任何赋型剂过敏的患者"}, {"probability": {"variance": 0.01689, "average": 0.930924, "min": 0.502756}, "location": {"width": 597, "top": 910, "height": 26, "left": 153}, "words": "2.1型糖尿病患者(胰岛素依赖型,IDDM),C-肽阴性糖尿病患者"}, {"probability": {"variance": 0.006237, "average": 0.956543, "min": 0.732401}, "location": {"width": 392, "top": 957, "height": 23, "left": 153}, "words": "3.伴随或不伴昏迷的糖尿病酮症酸中患者"}, {"probability": {"variance": 3e-06, "average": 0.998967, "min": 0.995522}, "location": {"width": 106, "top": 1005, "height": 23, "left": 123}, "words": "【注意事项】"}, {"probability": {"variance": 0.002069, "average": 0.981103, "min": 0.812919}, "location": {"width": 695, "top": 1050, "height": 27, "left": 158}, "words": "1同其它大多数口服促胰岛素分泌降血糖药物一样,瑞格列奈片也可致低血糖"}, {"probability": {"variance": 0.017409, "average": 0.95215, "min": 0.42005}, "location": {"width": 917, "top": 1098, "height": 27, "left": 152}, "words": "2与甲双胍台用会增加发生低血糖的危险性。如果合并用药后仍发生持续高血糖,则不能再用口服降"}, {"probability": {"variance": 7.4e-05, "average": 0.994287, "min": 0.968707}, "location": {"width": 354, "top": 1146, "height": 24, "left": 110}, "words": "血糖药控制血糖,而需改用胰岛素治疗"}, {"probability": {"variance": 0.001616, "average": 0.988876, "min": 0.742643}, "location": {"width": 901, "top": 1192, "height": 27, "left": 167}, "words": "在发生应激反应时,如发烧、外伤、感染或手术,可能会出现血糖控制失败。这时,有必要停止服用"}, {"probability": {"variance": 5.2e-05, "average": 0.995995, "min": 0.97583}, "location": {"width": 312, "top": 1240, "height": 26, "left": 108}, "words": "瑞格列奈而进行短期的胰岛素治疗"}, {"probability": {"variance": 0.009429, "average": 0.966368, "min": 0.571775}, "location": {"width": 578, "top": 1287, "height": 25, "left": 147}, "words": "4.瑞格列奈片尚未在18岁以下或75岁以上的患者中进行过研究"}, {"probability": {"variance": 0.001258, "average": 0.987765, "min": 0.788435}, "location": {"width": 923, "top": 1334, "height": 28, "left": 146}, "words": "5应尽量避免将瑞格列奈与吉非贝齐合用。如果必须合用,应严密监测患者的血糖水平。因为可能需要"}, {"probability": {"variance": 0.019635, "average": 0.940084, "min": 0.508381}, "location": {"width": 223, "top": 1384, "height": 24, "left": 109}, "words": "减少瑞格列奈的用药剂量"}, {"probability": {"variance": 0.002695, "average": 0.980977, "min": 0.73605}, "location": {"width": 620, "top": 1430, "height": 25, "left": 147}, "words": "6.与其它口服降血糖药一样,患者必须慎用以避免开车时发生低血糖"}, {"probability": {"variance": 0, "average": 0.955174, "min": 0.955174}, "location": {"width": 22, "top": 1438, "height": 27, "left": 1046}, "words": "8"}, {"probability": {"variance": 0.004689, "average": 0.966649, "min": 0.642643}, "location": {"width": 914, "top": 1467, "height": 37, "left": 151}, "words": "7肾功能不全:虽然瑞格列奈水平与肌酐清除率仅有微弱的联系,但本品的总血浆清除率在严重肾以能"}, {"probability": {"variance": 0.023969, "average": 0.945746, "min": 0.362234}, "location": {"width": 958, "top": 1525, "height": 27, "left": 105}, "words": "损伤的患者中略有降低。由于肾功能损伤的糖尿病患者对胰岛素敏感性增强,这些患者增加剂时应"}], "language": 3}